Das Handelsblatt hat das hessische Cannabis-Biotech-Unternehmen Avextra porträtiert und gibt Einblicke in die Arzneimittelentwicklung Made in Germany.
Home » Deutsches Start-up Avextra will „Cannabis-Blockbuster“ entwickeln
Das Handelsblatt hat das hessische Cannabis-Biotech-Unternehmen Avextra porträtiert und gibt Einblicke in die Arzneimittelentwicklung Made in Germany.
With your consent, we and third-party providers use cookies and similar technologies on our website to analyse your use of our site for market research purposes ("statistics"). This may result in the creation of pseudonymous usage profiles and the transfer of personal data to third countries, including the USA.
By clicking "Agree to all", you consent to the storage of the cookies and the processing for the purposes mentioned, including any transfers to third countries. If you click on "Decline", you do not give your consent and we will only store cookies that are necessary for our offer (Section 25 para. 2 Nr. 1 TTDSG). You can change your selection at any time under "Settings" or the "Cookie Button" on the right-hand side of the page and thus also withdraw your consent with effect for the future. You can find further information in our data protection declaration.